NecroX-5 alleviate lipopolysaccharide-induced acute respiratory distress syndrome by inhibiting TXNIP/NLRP3 and NF-kappa B

Fang, XZ; Ge, YL; Chen, ZY; Shu, HQ; Yang, YY; Yu, Y; Zhou, XJ; Chen, L; Cui, SN; Wang, YX; Yao, SL; Shang, Y

Shang, Y (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Crit Care Med, Wuhan 430022, Hubei, Peoples R China.; Yao, SL (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Anesthesiol, Wuhan 430022, Hubei, Peoples R China.

INTERNATIONAL IMMUNOPHARMACOLOGY, 2020; 81 ():